Portal de Periódicos da CAPES

Antinuclear Antibody–Negative Systemic Lupus Erythematosus in an International Inception Cohort

2018; Wiley; Volume: 71; Issue: 7 Linguagem: Inglês

10.1002/acr.23712

2151-4658

May Y. Choi, Ann E. Clarke, Yvan St. Pierre, John G. Hanly, Murray B. Urowitz, Juanita Romero‐Díaz, Caroline Gordon, Sang‐Cheol Bae, Sasha Bernatsky, Daniel J. Wallace, Joan T. Merrill, David Isenberg, Anisur Rahman, Ellen M. Ginzler, Michelle Petri, Ian N Bruce, Mary Anne Dooley, Paul R. Fortin, Dafna D. Gladman, Jorge Sánchez‐Guerrero, Kristján Steinsson, Rosalind Ramsey‐Goldman, Munther A. Khamashta, Cynthia Aranow, Graciela S. Alarcón, Susan Manzi, Ola Nived, Asad Zoma, Ronald van Vollenhoven, Manuel Ramos‐Casals, Guillermo Ruiz‐Irastorza, S. Sam Lim, Kenneth Kalunian, Murat İnanç, Diane L. Kamen, Christine A. Peschken, Søren Jacobsen, Anca Askanase, Thomas Stoll, Jill P. Buyon, Michael Mähler, Marvin J. Fritzler,

T-cell and B-cell Immunology

The spectrum of antinuclear antibodies (ANAs) is changing to include both nuclear staining as well as cytoplasmic and mitotic cell patterns (CMPs) and accordingly a change is occurring in terminology to anticellular antibodies. This study examined the prevalence of indirect immunofluorescence (IIF) anticellular antibody staining using the Systemic Lupus International Collaborating Clinics inception cohort.